FILTER VISION PUBLIC COMPANY LIMITED

1

Opportunity Day : Q1.2018May 22, 2018At The Stock Exchange of Thailand

Disclaimer

2

The information contained in this presentation is for information purposes only and does not constitute an offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for share in Filter Vision Public Company Limited(“FVC” and shares in FVC “shares”) in any jurisdiction nor should it or any part of it form the basis of, or be relied upon in any connection with, any contract or commitment whatsoever.

This presentation may include information which is forward-looking in nature. Forward-looking information involve known and unknown risks, uncertainties and other factors which may impact on the actual outcomes, including economic conditions in the markets in which FVC operates and general achievement of FVC business forecasts, which will cause the actual results, performance or achievements of FVC to differ, perhaps materially, from the results, performance or achievements expressed or implied in this presentation.

This presentation has been prepared by FVC. The information in this presentation has not been independently verified. No representation, warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information and opinions in this presentation. None of FVC or any of its agents or advisers, or any of their respective affiliates, advisers or representatives, shall have any liability (in negligence or otherwise) for any loss howsoever arising from any use of this presentation or its contents or otherwise arising in connection with thispresentation.

This presentation is made, furnished and distributed for information purposes only. No part of this presentation shall be reliedupon directly or indirectly for any investment decision-making or for any other purposes.

This presentation and all other information, materials or documents provided in connection therewith, shall not, either in wholeor in part, be reproduced, redistributed or made available to any other person, save in strict compliance with all applicablelaws.

Contents

3

Business Overview

Financial Information

Strategy and Outlook

Q & A

Contents

4

Business Overview

Financial Information

Strategy and Outlook

Q & A

Business Overview

5

FVCdistribute, design, assembly, install and preventive maintenance of water

treatment system and related products

Industrial & OEM

B1

Commercial & Residential

B2

Medical Service

B3

B3 (IRV) – Dialysis SOLN, Water and Facility for Hemodialysis(HD)

B3 (KTMS) – Hemodialysis CenterB3 (MV) – Pneumatic Tube SystemB3 (HHC) – Healthcare and aesthetics

Business Overview

6

B1 : Industrial and OEM

Reverse Osmosis System Automatic Regenerate Softener Filter

Semi Automatic Water Purifier

Business Overview

7

B1 : Industrial and OEM

Ultra FiltrationZero Discharge Wastewater Treatment System

Business Overview

8

B2 : Commercial and residential

UV System Prefilter R30-BB+7FC Triple+Claris L

Business Overview

9

B2 : Commercial and residential

RO system + Everpure High flow triple Water system for drinking water and ice machine

Business Overview

10

B3 : Medical service IRVING CORPORATION LIMITED

Pure Water Treatment System for HD Decoration for HD

Business Overview

11

B3 : Medical service IRVING CORPORATION LIMITED

Dialysate Solution Dialyzer Cabinet

Chemical Hood

Business Overview

12

B3 : Medical serviceKT MEDICAL SERVICE COMPANY LIMITED

KT Medical Service Hemodialysis Center

Business Overview

13

B3 : Medical service MEDICAL VISION COMPANY LIMITED

Pneumatic Tube System

Business Overview

14

B3 : Medical service HI HEALTHCARE CENTER COMPANY LIMITED

Healthcare and aesthetics clinic under trademark “Wuttisak Clinic”

Industrial & OEM (B1)

15

Customer Segments

Commercial & Residential (B2)

16

Customer Segments

Commercial & Residential (B2)

17

Customer Segments

Medical Service ( B3)

18

Customer Segments

19

Business Overview

Financial Information

Strategy and Outlook

Q & A

Content

302.86

360.75364.91

394.31

459.26

112.49144.09

0

100

200

300

400

500

2013 2014 2015 2016 2017 Q1'17 Q1'18

B111%

B243%

B346%

Q1’18 Revenue BreakdownRevenue

(Bt.mil) Q1’2017 Q1’2018increase/

decrease%

B1 20.63 16.43 -4.20 -20.36%

B2 57.63 62.13 4.50 7.81%B3 34.23 65.53 31.30 91.44%

Total 112.49 144.09 31.60 28.09% 20

Financial Information

Bt. mil

B118%

B251%

B331%

Q1’17 Revenue Breakdown

31.64%

27.21% 27.94% 28.59% 26.34% 28.10%

15.68%

2013 2014 2015 2016 2017 Q1'17 Q1'18

Gross Profit Margin

Gross Profit Margin

Gross profit margin decreased %, due to>> Some of revenue which increase has low margin. >> However, tend of revenue to increase continuously.

YoY-12.42%

21

Financial Information

Q1'17 Q2'17 Q3'17 Q4'17 Q1'17 Q1'18

6.43 5.97 6.89 6.35 6.43 6.15

12.71 13.57 13.84 14.35

12.71

17.32

6.53 6.656.64 7.02

6.53

7.64

Selling Admin Management

SG&A

YoY21.19%

Q1’18 SG&A Breakdown

(Bt.mil)

22

Financial Information

SG&A increased by 21.19 % :Mainly from Personnel expenses and expenses of the new subsidiary.

25.67 26.19 27.37 27.72

25.67 31.11

Personnel65%

Traveling5%

Office expense5%

Depreciation5%

Professional6%

Others14%

5.69 4.99

9.72

21.69

5.69

-6.3

5.06%

2.88%2.38%

4.72% 5.06%

-4.37%

-6.00%

-4.00%

-2.00%

0.00%

2.00%

4.00%

6.00%

(6.00)

(1.00)

4.00

9.00

14.00

19.00

24.00

1Q17 2Q17 3Q17 4Q17 Q1'17 Q1'18

Net Profit Net Profit Margin

Net Profit & Net Profit Margin(Bt.mil)

23

>> Revenue in new business has insufficient to cover the costs.>> Trend of sale and service income will grown as continues.

Financial Information

YoY-9.43%

YoY-210.72%

%

AMOUNT

100.00

200.00

300.00

400.00

500.00

600.00

700.00

800.00

900.00

2013 2014 2015 2016 2017 Q1'18

275.40 285.95

407.05 466.93

787.13 835.17

203.44 208.98

336.33 358.99

663.70 657.40

71.96 76.97

70.72 107.94

123.43 177.77

Asset Equity Liabilities

Balance Sheet(Bt.mil)

24

Assets >> Purchased assets amount 96.18 MB (from assets agreement amount 66.17 MB.).>> Account receivable in new business as increase amount 36.70 MB.>> Inventory in new business as increased amount 28.39 MB.>> Cash and cash equivalent decrease amount 130.34 MB.

Liabilities >> Account payable and unearned income in new business amounting 26.43 MB. >> Loan from financial institute amount 24.18 MB.

Financial Information

ROE

ROA

25

Financial Information

>> Investing in franchise cannot generate a good return in short term.

4.89%

1.67%2.17%

3.46% 3.46%

-3.11%

1Q17 2Q17 3Q17 4Q17 4Q17 1Q18

YoY 0.78%

6.29%

2.60%2.01%

4.24% 4.24%

-3.82%

1Q17 2Q17 3Q17 4Q17 4Q17 1Q18

QoQ-6.57%

QoQ-8.06%

D/E

26

QoQ0.08%

Financial Information

D/E ratio increased from previous year, due to >> Loan from financial institute amount 24.18 MB.>> Account payable and unearned income in new business amounting 26.43 MB.

0.27

0.14 0.14

0.19 0.19

0.27

1Q17 2Q17 3Q17 4Q17 4Q17 1Q18

27

Business Overview

Financial Information

Strategy and Outlook

Q & A

Content

28

Strategy and Outlook

o New Technology Product

o New Green& Environmental friendly

New Product Highlight

Water IntWater Injection

Intelligent

FVC Road Map

29

… NEXT SLIDE …- Operated the 2nd branch of Hemodialysis Center.- Purchase land in Chiang Mai province.- Capital increased to 342.79 MB.- On-line Hemodiafiltration.- Acquire Hemodialysis Center (the 3rd branch).- Special project for discount store.- Water treatment for dental (University Hospital).- Capital in subsidiary (KTMS) increased to 40.00 MB.- Entered MOU with “Wuttisak Clinic” to acquire the

business in total amount not exceeding 220 MB.

- Operated Hemodialysis Center.- Operated Pneumatic Tube System.

- Capital Increased to 195 MB.- Expand market to Medical Service Sector - Purchase land for new office and warehouse (BKK)

Restructure Technical Service Department “Water Treatment” & “Food Equipment”

IPO on October 29, 2013

2014

2016

2013

2015

2017

Q1.18 & plan to 2021

FVC Road Map

30

… NEXT SLIDE …

- Start with new office and warehouse (BKK) in May. - Operated 4th branch of Hemodialysis Center.- Launching Water INT.(The New Flagship)- New Local Marketing & Operation in healthcare and esthetics business.- ASEAN Medical Device Directive (AMDD) supported

by the government.

- Entered into a franchise agreement and an assets purchase agreement of “Wuttisak Clinic” 25 branches and operate in February 2018.

Q1.18

2019 -2021

Q2.18

- Sale target : 916.55 MB.- Exercised the 100 HD machines (Approximate)- Local Marketing for Wuttisak Clinic.- Recognize income from improve wastewater treatment

systems in state hospital amount 11.20 MB

2018

Sale force management

• Balancing The Business’s Portfolio• Uniformed Employer & Employee Branding• Operated a New Office, Warehouse, Dialysate Solution (North)• School of FVC : F&B Engineering & Medical Service• Supply Chain Mgmt. : Central operation center, Utilities' Mgmt.

Corporate

• Sale Target : 150-170 MB. In 2020• Contractor and O&M for WTP and WWTP.• Green & Energy Saving Technology for Special Application• R & D resources for FVC

B1

Industrial & OEM

31

FVC Road Map : Plan 2019 - 2021

Sale force management

• Sale Target : 350-380 MB. In 2020• Turned around knowledge base to be sale (Value added).• Water Int : The New Flagship• Analysed the Big Data for New Product & Service

B2

Commercial & Residential

• Sale Target : 300-500 MB. In 2020• Operation Synergised to Reducing Cost as well as

Standardized• Medical Engineering Support and Production : ASEAN Medical

Device Directive (AMDD),Good Distribution Practice for Medical Devices (GDPMDS).

• Increasing The Hemodialysis Operation (All Products): Forward & Backward Business

• Local Marketing & Operation for Wuttisak Clinic

B3

Medical Service

32

FVC Road Map : Plan 2019 -2021

Sale force management

• Contactor + O&M : Trading (80:20).• Green and energy saving technology.

B1

Industrial & OEM

• From base to be AR.• Rolling value added to business partner.

B2

Commercial & Residential

• Medical engineering, Inspiration for hope (HD), and FVC employee branding (healthcare and aesthetics).

B3

Medical Service

33

Strategy and Outlook

• Contractor + O&M : Trading (80:20)• Green and energy saving technology

-------------------------------------------------------• Sale force management• Project Management

B1

Industrial & OEM

34

Strategy and Outlook

Technology for Demineralized System and Waste Water Recycle System.

• Ultrafiltration• Reverse Osmosis• Ion Exchange resin.• EDI (Electrodeionization)

Water treatment system

Alkaline Drinking Water System

Renovated Water treatment system

Water Recycle Treatment system project

UV Disinfection for

F&B

40

Rainwater Inlet

STEP 1

STEP 2

STEP 3

STEP 4

Top Up Valve

Floating Suction Filter

RainwaterHarvesting

Tank

SmoothingInlet

• From base to be AR.• Rolling value added to business partner.

--------------------------------------------------------• Business partners’ satisfaction.• Analytical report.

B2

Commercial & Residential

42

Strategy and Outlook

One System with all sanitation aspects

2015 V1 BES Group 43

COMMERCIAL - PORTABLE AIR TREATMENT

OZONE GENERATOR

Green solution to odor control Kill viruses, germs, bacteria

from hotel rooms, clinics, homes, public spaces.

High Output, Hi-Efficiency Ultra Long Life American made UV Tube

On/Off switch with build-in LED 9 position electronic timer

Easily freshen a 100 m³ space in 10 minutes, and a 2,200 m³ space in about 2 hours or less.

Water IntWater Injection Intelligent

INNOVATION that increase an efficiency of air conditioning system. • Reduces condensing unit temperature • Increase performance of the system• Conserve electrical consumption ≥ 20%• Reduce system working hours• Increase condensing unit life time• Control module with protection sensor• Remote monitoring via mobile phone (optional)

• Medical engineering, Inspiration for hope (HD), and FVC employee branding (healthcare and aesthetics). -------------------------------------------------------------

• Strategy re-positioning in subsidiaries.• Medical standard competency.

B3

Medical Service

46

Strategy and Outlook

47

New Product Highlight

Pneumatic Tube Carrier System

48

Hemodialysis Center

New Product Highlight

49

New Product HighlightHealthcare and aesthetics clinic under trademark “Wuttisak Clinic”

50

Business Overview

Financial Information

Strategy and Outlook

Q & A

Content

51

52